Featured Insights and Perspectives from Darwin
The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
.jpg)
September 26, 2022
Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million
Learn More
September 26, 2022
Humana
acquisition
care
carepass
caregiver
October 3, 2022
Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial
Learn More
October 3, 2022
alzheimer
alzheimer's
pharma
biogen
October 10, 2022
Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues
Learn More
October 10, 2022
prescription drugs
drug
drugs
fda
.jpg)
October 17, 2022
business
business deals
common
commonspirit
October 24, 2022
Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports
Learn More
October 24, 2022
analytics
insurance
healthcare
hospital market concentrations
October 31, 2022
Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts
Learn More
October 31, 2022
Express Scripts
2020
health news
centene
.jpg)
November 7, 2022
Our Take: CMS hopes new changes to the Medicare Shared Savings Program will increase participation
Learn More
November 7, 2022
CMS
medicare
medicine
health
care
November 14, 2022
Our Take: With investments by Walgreens and Evernorth, VillageMD to acquire Summit Health-CityMD for $8.9 billion
Learn More
November 14, 2022
Walgreens
cleveland clinic
health
funding
.jpg)
December 21, 2022
Our Take: Sanford Health and Fairview Health Services will make another run at merging
Learn More
December 21, 2022
health
fee for service
health care service corp
merger
.jpg)
December 12, 2022
Our Take: CMS proposes new rule to automate and accelerate prior authorizations, says providers could save $15 billion over 10 years
Learn More
December 12, 2022
CMS
health news
healthcare news
health
December 19, 2022
Our Take: 2022: A year of multi-billion-dollar deals for industry disruptors
Learn More
December 19, 2022
business deals
business
health
January 9, 2023
Our Take: Eisai, Biogen get another chance with FDA’s accelerated approval of Alzheimer’s drug lecanemab
Learn More
January 9, 2023
biopharmaceutical
fda
alzheimer
biogen
biotech
Stay Aware. Stay Informed.
Want to stay ahead of health care trends?
Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
